Who Should I Start? Davante Adams or Malik Nabers

Monday, February 2, 9:44 AM

Los Angeles Rams head coach Sean McVay said on Monday that he has "no reason to believe" that wide receiver Davante Adams won't be back in 2026, according to ESPN's Sarah Barshop. Adams signed a two-year, $44 million contract with the team in March of last year, so the 33-year-old is under contract with the team through the 2026 campaign. In his first year in L.A. while working with McVay and quarterback Matthew Stafford, Adams showed he still has it, catching 60 of his 114 targets for 789 yards and a league-high 14 touchdowns in only 14 regular-season games. He wasn't all that efficient and took a back seat to star wideout Puka Nacua, but the six-time Pro Bowler was Stafford's go-to target in the red zone. Adams finished as the WR8 in half-PPR scoring. With Nacua not going anywhere as the target hog in this offense, Adams will be a regression candidate if he's unable to find the end zone as he did in 2025. There's also the chance of Adams' value tanking if Stafford retires this offseason.

Friday, February 6, 6:22 AM

New York Giants wide receiver Malik Nabers (knee) told ESPN's Jordan Raanan that his rehab has been "phenomenal." Nabers suffered a torn ACL and meniscus in his right knee on Sept. 28 and had surgery in late October. The 22-year-old's recovery time will be extended due to the full meniscus repair he underwent, in addition to his ACL surgery. However, since his injury occurred so early in the previous season, Nabers has a chance to be ready for the start of training camp in late July. We will be keeping a close eye on Nabers' progress throughout the offseason. The former sixth overall pick's progress as we approach training camp will determine his 2026 fantasy value. In his rookie campaign in 2024, Nabers caught 109 passes for 1,204 yards and seven touchdowns on 170 targets. With promising young quarterback Jaxson Dart now in the picture, Nabers' fantasy ceiling could be even higher despite suffering a significant knee injury in 2025.